Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Adverse Effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Isaac V., Makunts, Tigran, Atayee, Rabia, Abagyan, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431207/
https://www.ncbi.nlm.nih.gov/pubmed/28469132
http://dx.doi.org/10.1038/s41598-017-01590-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431207/
https://www.ncbi.nlm.nih.gov/pubmed/28469132
http://dx.doi.org/10.1038/s41598-017-01590-x

Ejemplares similares